Excluding PLND in favourable intermediate-risk prostate cancer: a PSMA-PET-directed perspective. Song D, Malshy K, Messing EM, Joseph JV, et al. Nat Rev Urol 2025 Oct 24. doi: 10.1038/s41585-025-01105.

Read + Share

Amedeo Smart

Independent Medical Education

Song D, Malshy K, Messing EM, Joseph JV, et al. Excluding PLND in favourable intermediate-risk prostate cancer: a PSMA-PET-directed perspective. Nat Rev Urol 2025 Oct 24. doi: 10.1038/s41585-025-01105.
PMID: 41136633